The Danish pharmaceutical giant continues to plummet and is down another 4.3 percent on the Copenhagen Stock Exchange. Also earlier in the week, the stock fell after a lowered profit forecast. In a week, 1,000 billion kronor of Novo Nordisk's market value have been lost, writes Dagens industri. In percentage, the stock has plummeted 33 percent in a week and is thus heading for its worst week ever.
With today's price drop, Novo Nordisk falls to a market value of just over 2,000 billion and is thus now smaller than sector colleague Astra Zeneca, writes Bloomberg. Novo Nordisk was previously one of Europe's highest-valued listed companies but is no longer on the list of the ten highest-valued companies.
Astra Zeneca is also losing today and is down 3.9 percent on the Stockholm Stock Exchange. This after the President of the USA, Donald Trump, wrote on his social media platform Truth Social that pharmaceutical companies have 60 days to lower prices for the American market.
